Lilly Announces Details of Presentations at 2021 American Association for Cancer ResearchMar 11, 202114 min
Sotorasib Provides Durable Clinical Benefit for Patients with NSCLC and KRAS Mutations Jan 25, 20213 min
The Improbable Targeted Therapy: KRAS as an Emerging Target in Non-Small Cell Lung CancerJan 19, 202123 min